ARCHIVES

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Study: Oncotype DX Score Can Predict Local Recurrence

March 29, 2013

Tobacco Control: Cigarette Price Hikes Reduce Smoking, Study Confirms

August 7, 1998

Clinical Oncology Programs Extended Two Years; No Decision Yet On Further Expansion

November 3, 1978

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

February 24, 2006

Chaos In Congress Killed $20 Million Increase For NCI

December 19, 1980

ONS Membership Still Climbing, Soars over 15,000

June 23, 1989